Patrick Gallagher
Founder at Cingulate Therapeutics LLC
Net worth: 12 917 $ as of 2024-03-30
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Matthew Patrick Duffy | M | 61 |
Cowen Prime Services LLC
Cowen Prime Services LLC Investment Banks/BrokersFinance Cowen Prime Services LLC (CPS) is a broker-dealer headquartered in New York City. The firm is directly owned by Cowen PB Holdings LLC, which, in turn, is primarily owned by Cowen Group, Inc. (NASDAQ: COWN). CPS is registered as a broker-dealer with the SEC and FINRA, and as a an introducing broker with the Commodities Futures Trading Commission and the National Futures Association. CPS was formed in 2015 following Cowen Group’s acquisition of Concept Capital Markets LLC. Concept Capital was established in 2010 following the spin-off of the Concept Capital division of Sanders Morris Harris Inc., whose origins date back to 1995. CPS' offering includes world-class custody and clearing options, multi asset class capabilities, leading execution and order management systems, a seasoned execution desk, a range of financing options, a highly professional operations and customer support team, comprehensive portfolio reporting capabilities, capital introduction, and live, intraday and post-trade risk and performance analytics.
Pd Theranostics, Inc.
Pd Theranostics, Inc. Packaged SoftwareTechnology Services Pd Theranostics, Inc. develops algorithms for prostate cancer and diabetic foot ulcers patience. The company is headquartered in New York, NY.
Voltron Therapeutics, Inc.
Voltron Therapeutics, Inc. BiotechnologyHealth Technology Voltron Therapeutics, Inc. develops the vaccine and immunotherapy center. The company was founded in 2017 and is headquartered in New York, NY.
Aerwave Medical, Inc.
Aerwave Medical, Inc. Medical/Nursing ServicesHealth Services Aerwave Medical, Inc. is a company that is developing a unique alternative to traditional medications used to treat pulmonary diseases such as asthma and COPD. The company is based in New York, NY, and the CEO of the company is Jeffrey Francis O'Donnell. These diseases are characterized by an unmet medical need, with up to 15% of asthma patients and 25% of COPD patients being unresponsive to treatment. Additionally, around 50% of long-term inhaler users discontinue use within the first year due to compliance issues and multiple side effects. Aerwave Medical's revolutionary approach involves an interventional method to treat these diseases.
Laidlaw & Co. (UK) Ltd.
Laidlaw & Co. (UK) Ltd. Investment Banks/BrokersFinance Part of Laidlaw Holdings Ltd., Laidlaw & Co. (UK) Ltd. is a British company that provides investment advice. The private company is based in London, UK. The company was founded in 1842. Matthew D. Eitner has been the CEO of the company since 2010.
Laidlaw Private Equity, LLC
Laidlaw Private Equity, LLC Investment ManagersFinance Laidlaw Private Equity LLC (Laidlaw Private Equity) is a venture capital subsidiary of Laidlaw & Co(UK) Ltd founded by James Ahern. The firm is headquartered in New York. | 6 years |
Craig Gilgallon | M | 52 |
Cingulate Therapeutics LLC
Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS.
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | 11 years |
Shane Schaffer | M | 49 |
Cingulate Therapeutics LLC
Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS.
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | 11 years |
Jeffrey Conroy | M | 59 |
Cingulate Therapeutics LLC
Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS.
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | 6 years |
Jeff Hargroves | M | 58 |
Cingulate Therapeutics LLC
Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS.
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | 6 years |
Jeffrey O'Donnell | M | 64 |
Aerwave Medical, Inc.
Aerwave Medical, Inc. Medical/Nursing ServicesHealth Services Aerwave Medical, Inc. is a company that is developing a unique alternative to traditional medications used to treat pulmonary diseases such as asthma and COPD. The company is based in New York, NY, and the CEO of the company is Jeffrey Francis O'Donnell. These diseases are characterized by an unmet medical need, with up to 15% of asthma patients and 25% of COPD patients being unresponsive to treatment. Additionally, around 50% of long-term inhaler users discontinue use within the first year due to compliance issues and multiple side effects. Aerwave Medical's revolutionary approach involves an interventional method to treat these diseases. | 7 years |
Peter Werth | M | 85 |
Cingulate Therapeutics LLC
Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS.
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | 6 years |
Matthew Brams | M | 61 |
Cingulate Therapeutics LLC
Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS.
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | 11 years |
Gregg William Givens | M | 63 |
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | 3 years |
Laurie Myers | M | 67 |
Cingulate Therapeutics LLC
Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS.
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | 11 years |
Paul Korner | M | 58 |
Laidlaw Private Equity, LLC
Laidlaw Private Equity, LLC Investment ManagersFinance Laidlaw Private Equity LLC (Laidlaw Private Equity) is a venture capital subsidiary of Laidlaw & Co(UK) Ltd founded by James Ahern. The firm is headquartered in New York.
Voltron Therapeutics, Inc.
Voltron Therapeutics, Inc. BiotechnologyHealth Technology Voltron Therapeutics, Inc. develops the vaccine and immunotherapy center. The company was founded in 2017 and is headquartered in New York, NY. | 4 years |
Curt Medeiros | M | 48 |
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | 3 years |
Jennifer Callahan | F | 53 |
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | 7 years |
Raul Silva | M | 66 |
Cingulate Therapeutics LLC
Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS.
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | 11 years |
Anthony Zook | M | 63 |
Voltron Therapeutics, Inc.
Voltron Therapeutics, Inc. BiotechnologyHealth Technology Voltron Therapeutics, Inc. develops the vaccine and immunotherapy center. The company was founded in 2017 and is headquartered in New York, NY. | 4 years |
Matthew D. Eitner | M | - |
Voltron Therapeutics, Inc.
Voltron Therapeutics, Inc. BiotechnologyHealth Technology Voltron Therapeutics, Inc. develops the vaccine and immunotherapy center. The company was founded in 2017 and is headquartered in New York, NY.
Laidlaw & Co. (UK) Ltd.
Laidlaw & Co. (UK) Ltd. Investment Banks/BrokersFinance Part of Laidlaw Holdings Ltd., Laidlaw & Co. (UK) Ltd. is a British company that provides investment advice. The private company is based in London, UK. The company was founded in 1842. Matthew D. Eitner has been the CEO of the company since 2010. | 14 years |
Tony N Hodges | M | - |
Laidlaw Private Equity, LLC
Laidlaw Private Equity, LLC Investment ManagersFinance Laidlaw Private Equity LLC (Laidlaw Private Equity) is a venture capital subsidiary of Laidlaw & Co(UK) Ltd founded by James Ahern. The firm is headquartered in New York. | 4 years |
Louis van Horn | M | 65 |
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | 7 years |
Zachary Koch | M | - | 2 years | |
Thomas Dalton | M | - | 3 years | |
Arthur B. Straughn | M | - |
Cingulate Therapeutics LLC
Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS. | - |
James Ahern | M | - |
Voltron Therapeutics, Inc.
Voltron Therapeutics, Inc. BiotechnologyHealth Technology Voltron Therapeutics, Inc. develops the vaccine and immunotherapy center. The company was founded in 2017 and is headquartered in New York, NY.
Laidlaw Private Equity, LLC
Laidlaw Private Equity, LLC Investment ManagersFinance Laidlaw Private Equity LLC (Laidlaw Private Equity) is a venture capital subsidiary of Laidlaw & Co(UK) Ltd founded by James Ahern. The firm is headquartered in New York. | 6 years |
George Serafin | M | - |
Laidlaw & Co. (UK) Ltd.
Laidlaw & Co. (UK) Ltd. Investment Banks/BrokersFinance Part of Laidlaw Holdings Ltd., Laidlaw & Co. (UK) Ltd. is a British company that provides investment advice. The private company is based in London, UK. The company was founded in 1842. Matthew D. Eitner has been the CEO of the company since 2010. | - |
Andrew Gornell Ballou | M | - | 5 years | |
John Baratta | M | - |
Cowen Prime Services LLC
Cowen Prime Services LLC Investment Banks/BrokersFinance Cowen Prime Services LLC (CPS) is a broker-dealer headquartered in New York City. The firm is directly owned by Cowen PB Holdings LLC, which, in turn, is primarily owned by Cowen Group, Inc. (NASDAQ: COWN). CPS is registered as a broker-dealer with the SEC and FINRA, and as a an introducing broker with the Commodities Futures Trading Commission and the National Futures Association. CPS was formed in 2015 following Cowen Group’s acquisition of Concept Capital Markets LLC. Concept Capital was established in 2010 following the spin-off of the Concept Capital division of Sanders Morris Harris Inc., whose origins date back to 1995. CPS' offering includes world-class custody and clearing options, multi asset class capabilities, leading execution and order management systems, a seasoned execution desk, a range of financing options, a highly professional operations and customer support team, comprehensive portfolio reporting capabilities, capital introduction, and live, intraday and post-trade risk and performance analytics. | 13 years |
Gary Gemignani | M | 59 |
Laidlaw Private Equity, LLC
Laidlaw Private Equity, LLC Investment ManagersFinance Laidlaw Private Equity LLC (Laidlaw Private Equity) is a venture capital subsidiary of Laidlaw & Co(UK) Ltd founded by James Ahern. The firm is headquartered in New York. | 3 years |
Brenda Castrodad | F | - | 3 years | |
Mark McGoldrick | M | - |
Cowen Prime Services LLC
Cowen Prime Services LLC Investment Banks/BrokersFinance Cowen Prime Services LLC (CPS) is a broker-dealer headquartered in New York City. The firm is directly owned by Cowen PB Holdings LLC, which, in turn, is primarily owned by Cowen Group, Inc. (NASDAQ: COWN). CPS is registered as a broker-dealer with the SEC and FINRA, and as a an introducing broker with the Commodities Futures Trading Commission and the National Futures Association. CPS was formed in 2015 following Cowen Group’s acquisition of Concept Capital Markets LLC. Concept Capital was established in 2010 following the spin-off of the Concept Capital division of Sanders Morris Harris Inc., whose origins date back to 1995. CPS' offering includes world-class custody and clearing options, multi asset class capabilities, leading execution and order management systems, a seasoned execution desk, a range of financing options, a highly professional operations and customer support team, comprehensive portfolio reporting capabilities, capital introduction, and live, intraday and post-trade risk and performance analytics. | 13 years |
Katie Freshwater | F | - | 2 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Frederick Hrkac | M | 58 | 2 years | |
Greg Cash | M | 66 | 3 years | |
Donald Foley | M | 73 | 9 years | |
William A. Henderson | M | - |
The Pennsylvania State University
| 10 years |
Roy Tanaka | M | 75 | 7 years | |
Robert John Fisher | M | - |
The Pennsylvania State University
| 1 years |
Andrew Filler | M | 56 | 4 years | |
James Klein | M | 59 | 2 years | |
Steven J. Ritter | M | - |
University of Vermont
The Pennsylvania State University
| 8 years |
Gerald McGuire | M | 62 |
University of Vermont
| 8 years |
Matt Goodhart | M | - |
Cowen Prime Services LLC
Cowen Prime Services LLC Investment Banks/BrokersFinance Cowen Prime Services LLC (CPS) is a broker-dealer headquartered in New York City. The firm is directly owned by Cowen PB Holdings LLC, which, in turn, is primarily owned by Cowen Group, Inc. (NASDAQ: COWN). CPS is registered as a broker-dealer with the SEC and FINRA, and as a an introducing broker with the Commodities Futures Trading Commission and the National Futures Association. CPS was formed in 2015 following Cowen Group’s acquisition of Concept Capital Markets LLC. Concept Capital was established in 2010 following the spin-off of the Concept Capital division of Sanders Morris Harris Inc., whose origins date back to 1995. CPS' offering includes world-class custody and clearing options, multi asset class capabilities, leading execution and order management systems, a seasoned execution desk, a range of financing options, a highly professional operations and customer support team, comprehensive portfolio reporting capabilities, capital introduction, and live, intraday and post-trade risk and performance analytics. | 1 years |
Jerome Zeldis | M | 74 | 1 years | |
Kalyanam Shivkumar | M | 56 | 2 years | |
Scott Applebaum | M | 57 | 1 years | |
James Barry | M | 64 | 3 years | |
Samuel Navarro | M | 68 | 3 years | |
Steven Chaussy | M | 70 | 12 years | |
Bob Ai | M | 60 |
The Pennsylvania State University
| 4 years |
Tiffini Wittwer | F | - | - | |
Martha Pease | F | 66 | 2 years | |
David Weild | M | 67 | 9 years | |
Natasha Drapeau | F | - | 5 years | |
Jennifer Moses | F | 49 |
The Pennsylvania State University
| 4 years |
Jack A. Shindle | M | - |
The Pennsylvania State University
| 4 years |
Juan Mauricio Benavides Estévez-Bretón | M | 68 |
The Pennsylvania State University
| 4 years |
Stephen Waltrich | M | - |
The Pennsylvania State University
| 4 years |
Jennifer Shea | F | - |
The Pennsylvania State University
| 4 years |
Walter Grollitsch | M | - |
The Pennsylvania State University
| 3 years |
Larry Gilbert | M | - |
The Pennsylvania State University
| 4 years |
Bobby Karnadi Gandasaputra | M | 49 |
The Pennsylvania State University
| 4 years |
M. Andrews Yeo | M | - |
The Pennsylvania State University
| 4 years |
Jonathon Nudi | M | 53 |
The Pennsylvania State University
| 4 years |
William M. Smith | M | - |
The Pennsylvania State University
| 4 years |
Jason L. Hertzberg | M | - |
The Pennsylvania State University
| 4 years |
Bradley L. Ottinger | M | 54 |
The Pennsylvania State University
| 4 years |
Jon Moffett | M | - |
The Pennsylvania State University
| 4 years |
Jon Eckhardt | M | - |
The Pennsylvania State University
| 4 years |
Paul Kutufaris | M | - |
The Pennsylvania State University
| 4 years |
Bill Starnes | M | - |
The Pennsylvania State University
| 4 years |
Kemal Anbarci | M | - |
The Pennsylvania State University
| 5 years |
Vincent Sorgi | M | 52 |
The Pennsylvania State University
| 4 years |
Sandy Matalonis | F | - |
The Pennsylvania State University
| 4 years |
Heidi Anderson | F | 53 |
The Pennsylvania State University
| 4 years |
Terry W. Melton | M | - |
The Pennsylvania State University
| 3 years |
Ricardo J. Gonzalez | M | 53 |
The Pennsylvania State University
| 4 years |
L. J. Rowell | M | 91 |
The Pennsylvania State University
| 16 years |
Glenn J. Gazdik | M | - |
The Pennsylvania State University
| 4 years |
Leon Arthur Root | M | - |
The Pennsylvania State University
| 4 years |
Chip Baird | M | 52 |
The Pennsylvania State University
| 4 years |
Craig Robert Chobor | M | 52 |
The Pennsylvania State University
| 4 years |
Joseph Altobello | M | - |
The Pennsylvania State University
| 4 years |
France Córdova | M | 84 |
The Pennsylvania State University
| 4 years |
Todd Burnside | M | - |
The Pennsylvania State University
| 4 years |
Ryan Ludt | M | - |
The Pennsylvania State University
| 4 years |
Jason Gorelkin | M | - |
The Pennsylvania State University
| 4 years |
Bruce Booth | M | 49 |
The Pennsylvania State University
| 4 years |
Susan Lynn Arnold | F | - |
The Pennsylvania State University
| 4 years |
Marc Selfon | M | - |
The Pennsylvania State University
| 4 years |
Scott Gallagher | M | - |
The Pennsylvania State University
| 4 years |
Abdul Farid bin Alias | M | 56 |
The Pennsylvania State University
| 4 years |
Jeff Vittorio | M | - |
The Pennsylvania State University
| 4 years |
Todd Spear | M | - |
The Pennsylvania State University
| 4 years |
Kevin Dyson | M | - |
The Pennsylvania State University
| 4 years |
Marianne Payne | F | - |
The Pennsylvania State University
| 4 years |
Christian Marrone | M | - |
The Pennsylvania State University
| 4 years |
Scott Vassalluzzo | M | 53 |
The Pennsylvania State University
| 4 years |
Igor Jablokov | M | - |
The Pennsylvania State University
| 6 years |
Paul C. Brown | M | - |
The Pennsylvania State University
| 4 years |
Michael J. Chizmar | M | - |
The Pennsylvania State University
| 4 years |
Venable Jake | M | - |
The Pennsylvania State University
| 4 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 98 | 98.99% |
United Kingdom | 3 | 3.03% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Patrick Gallagher
- Personal Network